Results 21 to 30 of about 17,905 (230)
Antimicrobial Agents and Chemotherapy, 2023 Candida (Clavispora) lusitaniae is a rare, emerging non-albicans Candida species that can cause life-threatening invasive infections, spread within hospital settings, and rapidly acquire antifungal drug resistance, including multidrug resistance.
N. E. Scott +3 more
semanticscholar +1 more source
International Journal of Antimicrobial Agents, 2023 OBJECTIVES Invasive Aspergillus infections during the early phase of childhood acute lymphoblastic leukemia (ALL) treatment come with morbidity and mortality. The interaction with vincristine hampers first-line azole prophylaxis. We describe the efficacy
D. Bury +6 more
semanticscholar +1 more source
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Background: Fungal diseases are associated with substantial global mortality and economic burden, especially in critically ill or immunocompromised patients.
Radhika Arya +3 more
doaj +1 more source
Medical Mycology Case Reports, 2020 We report a rare case of C. krusei knee arthritis treated with instillation of micafungin and arthroscopy. A 49-year-old man hospitalized for treatment of Acute Myeloid Leukemia developed knee arthritis with C. krusei.
Jeroen C. van Egmond +3 more
doaj +1 more source
Antimicrobial Agents and Chemotherapy, 2023 Procedures such as solid-organ transplants and cancer treatments can leave many patients in an immunocompromised state. This leads to their increased susceptibility to opportunistic diseases such as fungal infections.
Alexis García, E. Huh, Soo Chan Lee
semanticscholar +1 more source
Journal of Infection in Developing Countries, 2021 Introduction: An echinocandin, such as micafungin, is recommended as first-line treatment for invasive Candida infections in immunocompromised patients. This multicenter, observational, prospective, non- interventional study evaluated the real-world use
Samo Zver +8 more
doaj +1 more source
Microorganisms, 2021 Candida auris is an emerging and frequently multidrug-resistant pathogen against which the echinocandins are the preferred therapeutic option. We compared killing activities of anidulafungin, caspofungin, micafungin, and rezafungin against 13 isolates ...
R. Kovács +7 more
semanticscholar +1 more source
Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis. [PDF]
PLoS ONE, 2015 Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause of invasive candidiasis; however, infections due to non-C.
Sandra Gil-Alonso +3 more
doaj +1 more source
Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]
, 2017 The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew +6 more
core +4 more sources
Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB. [PDF]
, 2016 Repurposing has gained momentum globally and become an alternative avenue for drug discovery because of its better success rate, and reduced cost, time and issues related to safety than the conventional drug discovery process.
Brindha, Sridharan +4 more
core +1 more source